Dfine has announced that at the annual meeting of the American Society of Clinical Oncology (ASCO; 31 May–4 June, Chicago, USA), a study showed that its targeted radiofrequency ablation system (t-RFA; Star) was associated with safe and effective pain relief in patients with soft tissue sarcomas—highlighting successful treatment outcomes in radioresistant tumours with the system.
Researchers at Albert Einstein College of Medicine, of Yeshiva University, New York, USA, have shown, according to a press release, that football players who frequently head the ball have brain abnormalities resembling those found in patients with concussion (mild traumatic brain injury). The study, which used advanced imaging techniques and cognitive tests that assessed memory, was recently published online in the journal Radiology.
Codman Neuro has announced at the Live Interventional Neuroradiology and Neurosurgery Course (LINNC) in Paris, France, that it has obtained CE marking for the REVIVE SE, a self-expanding clot removal device for use in treating acute ischaemic stroke.
Sequent Medical announced that it has received CE Mark approval for its Single-Layer family of Web aneurysm embolisation devices and has commenced a controlled release of these new models in select neurovascular centres in Europe, according to the company.
Medically managed patients with asymptomatic severe carotid artery stenosis develop ipsilateral neurological symptoms early, according to a study presented at the Vascular Annual Meeting (30 May–1 June 2013) in San Francisco, USA. In the study, the use of statins and aspirin failed to prevent neurological symptoms.
MRI Interventions and IMRIS announced that a surgical team at a USA neuroscience institution has delivered the investigational gene therapy drug Toca 511 directly into a glioblastoma brain tumour using real-time intraoperative MRI (iMRI) guidance within an IMRIS VISIUS Surgical Theatre. MRI Interventions’ ClearPoint neurointervention system was reported as being used as the navigation platform and the ClearPoint SmartFlow large-bore cannula as the vehicle for delivery of the therapeutic agent.
Ciertos cambios en el estilo de vida podrían reducir mucho el riesgo de accidente cerebrovascular (ACV), según un estudio reciente. Los investigadores calcularon el riesgo de ACV entre casi 23,000 estadounidenses negros y blancos a partir de los 45 años de edad.
Dfine, the developer of minimally invasive radiofrequency targeted therapies for the treatment of vertebral pathologies, released study results highlighting the clinical benefits of advanced Targeted-Radiofrequency Ablation(t-RFA) therapy for the management of patients experiencing painful spinal lesions. Eighty-five per cent of patients with metastatic disease will develop spinal metastases—of these nearly 75% will involve the axial skeleton.
En un estudio sobre militares de Estados Unidos en el exterior, aquellos con múltiples traumatismos de cráneo eran más propensos a tener pensamientos suicidas que los que habían sufrido una o ninguna de esas lesiones. "El personal militar con más de un traumatismo de cráneo en su vida era significativamente más propenso a haber intentado suicidarse en el pasado y en el último año", comentó el autor principal, Craig Bryan, del Centro Nacional para los Estudios sobre los Veteranos de University of Utah, Salt Lake City.
Durante las dos próximas décadas, se espera que el costo de tratar los accidentes cerebrovasculares (ACV) en EE. UU. se duplique y más, superando los 180 mil millones de dólares al año, según una investigación reciente. El principal factor subyacente del aumento es el envejecimiento de la población. El informe, de la Asociación Americana del Corazón (American Heart Association, AHA) y la Asociación Americana del Accidente Cerebrovascular (American Stroke Association), aparece en la edición del 22 de mayo de la revista Stroke.
Sequent Medical, Inc. (Aliso Viejo, CA) announced that it has received CE Mark approval for the SL (single-layer) family of Web aneurysm embolization devices and has commenced a controlled release of these new models in select neurovascular centers in Europe. The SL family offers a lower profile and excellent navigability that will enable physicians to treat a broader range of aneurysms with the Web platform, the company stated.
Sequent Medical, Inc. announced today that it has received CE mark for the SL ("Single Layer") family of WEB® Aneurysm Embolization Devices, and has commenced a controlled release of these new models in select neurovascular centers in Europe. The SL family offers a lower profile and superior navigability that will enable physicians to treat a broader range of aneurysms with the WEB platform.
The Society for Cardiovascular Angiography and Interventions (SCAI) announced the presentation of a CREST (Carotid Revascularization Endarterectomy versus Stenting Trial) substudy at the SCAI 2013 scientific sessions in Orlando, Florida. The objective of this substudy was to evaluate whether undergoing angioplasty after carotid stenting increases the risk of complications such as stroke.
Un estudio de gran tamaño mostró que las personas mayores que seguían la dieta tenían una mejor retención de las habilidades mentales
Physicians at Ronald Reagan UCLA Medical Center are the first on the West Coast to perform a new, less-invasive procedure that is part of a clinical trial to help clear plaque from the carotid arteries, according to a release. The procedure took place on 28 March.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos